LLY News
-
LLY neutral
Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance
finance.yahoo.com·Jun 12, 2026·Eli Lilly and Company (NYSE:LLY) is one of the 7 Best Compounder Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) plans to stop providing 340B discounted d...
-
LLY bullish
Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data
rttnews.com·Jun 12, 2026·This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acq...
-
LLY bullish
SonoThera Raises $125M to Advance Gene Therapy
ventureburn.com·Jun 11, 2026·The funding was led by Vida Ventures with participation from major healthcare investors. SonoThera Inc. has secured a $125 million funding round to advance the...
-
LLY neutral
10 Good Stocks to Invest In Now
insidermonkey.com·Jun 11, 2026·In this article, we will look at the 10 Good Stocks to Invest In Now. On June 10, Tom Lee appeared on a CNBC Television interview to discuss the latest market ...
-
LLY neutral
10 Best Forever Stocks to Buy According to Analysts
insidermonkey.com·Jun 10, 2026·In this article, we will discuss the 10 Best Forever Stocks to Buy According to Analysts. Rising expectations of the US Federal Reserve hiking interest rates i...
-
LLY bullish
Is Eli Lilly and Company (LLY) One of the 10 Best Dividend Stocks to Buy According to D. E. Shaw?
insidermonkey.com·Jun 10, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
-
LLY neutral
Is Eli Lilly and Company (LLY) One of the 10 Best Dividend Stocks to Buy According to D. E. Shaw?
finance.yahoo.com·Jun 10, 2026·Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Dividend Stocks to Buy According to D. E. Shaw. Is Eli Lilly and Company (LLY) One of the 10 Bes...
-
LLY bullish
Eli Lilly and Company (LLY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com·Jun 9, 2026·Question-and-Answer Session Ken, let's just get straight to the discussion, just to tee you up high level, and we're going to talk about your -- a lot of your ...
-
LLY neutral
Eli Lilly: Bears Are Missing The Underlying Thesis (NYSE:LLY)
seekingalpha.com·Jun 9, 2026·Eli Lilly and Company ( LLY ) has been the strongest performing big pharma company over the last year. It's up 50% in the last year compared to Novo Nordisk A/S...
-
LLY neutral
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
manilatimes.net·Jun 9, 2026·The Treg cell-based therapies clinical trial analysis report delivers important insights into ongoing research on 35+ Treg cell-based therapies in the pipeline,...
-
LLY neutral
Is Trending Stock Eli Lilly and Company (LLY) a Buy Now?
zacks.com·Jun 8, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
-
LLY neutral
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing
finance.yahoo.com·Jun 6, 2026·Two drugs make up nearly two-thirds of Eli Lilly's (NYSE: LLY) top line, generating around $12.8 billion in revenues in the first quarter of 2026. The two drugs...
-
LLY neutral
Jim Cramer Says Eli Lilly CEO Is a “Terrific Steward of His Shareholders’ Capital”
finance.yahoo.com·Jun 6, 2026·Eli Lilly and Company (NYSE:LLY) was among the stocks on which Jim Cramer gave his opinion, as he warned that increased AI-related spending might cause near-ter...
-
LLY bearish
Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN
rttnews.com·Jun 5, 2026·This week, the biotech sector saw a wave of regulatory approvals in the U.S., alongside study halts, strategic collaborations, acquisitions, deal closures, and ...
-
LLY neutral
TD Cowen Lifts GLP-1 Market Outlook, Sees Global Sales Reaching $150 Billion by 2030
finance.yahoo.com·Jun 5, 2026·ozempic weight loss drugs GLP-1 NEW SIZE ©chemist4u TD Cowen has raised its long-term forecast for the global GLP-1 market, projecting annual sales of diabete...
-
LLY neutral
IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight
manilatimes.net·Jun 4, 2026·The IgE receptor antagonists clinical trial analysis report delivers important insights into ongoing research on 12+ IgE receptor antagonists in the pipeline, c...